RJFSA
NMTR

Raymond James Financial Services Advisors’s 9 Meters Biopharma NMTR Stock Holding History

Raymond James Financial Services Advisors’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,609
Closed -$26K – 3116
2020
Q3 		$26K Buy
1,609
+250
+18% +$3.03K ﹤0.01% 2808
2020
Q2 		$16K Buy
1,359
+700
+106% +$7.89K ﹤0.01% 2773
2020
Q1 		$7K Buy
659
+140
+27% +$1.75K ﹤0.01% 2402
2019
Q4 		$6K Buy
+519
New +$8.64K ﹤0.01% 2836
2018
Q1 		– Sell
-109
Closed -$13K – 2770
2017
Q4 		$13K Hold
109
– – ﹤0.01% 2515
2017
Q3 		$15K Hold
109
– – ﹤0.01% 2530
2017
Q2 		$11K Hold
109
– – ﹤0.01% 2499
2017
Q1 		$26K Hold
109
– – ﹤0.01% 2350
2016
Q4 		$38K Buy
+109
New +$31.6K ﹤0.01% 2253

Other funds holding NMTR

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TLP
Tri Locum Partners New York $713M AUM 68.92% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return

Raymond James Financial Services Advisors's NMTR Position: Q4 2020 in Review

Raymond James Financial Services Advisors sold out of 9 Meters Biopharma (NMTR) in Q4 2020, closing a stake of 1,609 shares — an estimated $26K sold.

Raymond James Financial Services Advisors first reported a position in NMTR in Q4 2016 and held it in 9 quarters. The position peaked at $38K in Q4 2016. 57 funds tracked by Wall St. Rank hold NMTR as of Q4 2020.

  • Raymond James Financial Services Advisors reported no remaining 9 Meters Biopharma position as of Q4 2020 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 1,609 9 Meters Biopharma shares in Q4 2020, an estimated $26K.
  • Raymond James Financial Services Advisors first reported a position in 9 Meters Biopharma in Q4 2016 and held it in 9 quarters.
  • Raymond James Financial Services Advisors's 9 Meters Biopharma position peaked at $38K in Q4 2016.
  • 57 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q4 2020.

Based on Raymond James Financial Services Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.